(Reuters) - The clinical-stage biopharmaceutical company said it
applied for a Nasdaq listing under the symbol "QURK."
Read more at Reuters.com Bonds News
applied for a Nasdaq listing under the symbol "QURK."
Read more at Reuters.com Bonds News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment